|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.945 USD | -4.25% |
|
-2.83% | -38.93% |
| 05-14 | Aquestive Therapeutics, Inc., Q1 2026 Earnings Call, May 14, 2026 | |
| 05-14 | Aquestive Therapeutics Inc - enters five-year term loan facility of up to $150 million on May 12, 2026 - SEC filing | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 5.03 | 5.03 | 7.08 |
| Spread/Res. | -21.57% | -21.57% | -44.28% |
| Spread/Supp. | +0.90% | +0.90% | +33.73% |
| Support | 3.91 | 3.91 | 2.95 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AQST Stock
- Charts Aquestive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
